Literature DB >> 12660426

Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES.

Mikako Aoki1, Ruby Pawankar, Yayoi Niimi, Seiji Kawana.   

Abstract

BACKGROUND: Basal cell carcinoma (BCC) is the most common malignant tumor of the skin. Although an increase in mast cell infiltration was observed in BCC lesions, definite evidence of an active role of mast cells in the pathogenesis of BCC is still lacking. BCC is accompanied by cellular infiltrates. Moreover, the stroma in the BCC lesions is characterized by an increased number of mast cells and increased vascularity. The aim of this study was to elucidate the probable role of mast cells in BCC, especially focusing on the relationship between mast cells and lymphocytic infiltration as well as angiogenesis.
METHODS: We examined the expression and distribution of VEGF, IL-8 and RANTES in 16 nodular BCC lesions by immunohistochemistry. We also examined the lymphocyte subset, and the correlation between VEGF expression and microvessel density in the BCC lesion. mRNA expression of IL-8 and RANTES was examined by the reverse transcriptase-polymerase chain reaction.
RESULTS: T cells, especially CD4+/CD45RO+ memory T cells were the predominant infiltrating lymphocyte population in BCC lesions. An increased number of tryptase+ cells (mast cells) was found in the stroma. VEGF+/IL-8+/RANTES+ cells were also found abundantly in the stroma of all BCC lesions. The number of VEGF+, IL-8+ and RANTES+ cells was significantly higher than that in controls. By immunohistochemistry of serial sections, tryptase+ cells were found to express VEGF, IL-8 or RANTES. Messenger RNA expression of IL-8 and RANTES was also observed in the BCC lesions.
CONCLUSION: This study suggests that mast cells may play an active role in the angiogenesis of BCC through the production of VEGF and IL-8. Furthermore, mast cells may also regulate lymphocytic infiltration through the production of IL-8 and RANTES. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660426     DOI: 10.1159/000069515

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  29 in total

1.  Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases.

Authors:  S Epari; M C Sharma; C Sarkar; A Garg; A Gupta; V S Mehta
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

2.  Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues.

Authors:  Shao-Hua Peng; Hong Deng; Jian-Feng Yang; Ping-Ping Xie; Cheng Li; Hao Li; De-Yun Feng
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

3.  A transcriptomic insight into the impacts of mast cells in lung, breast, and colon cancers.

Authors:  Eun-A Ko; Kenton M Sanders; Tong Zhou
Journal:  Oncoimmunology       Date:  2017-08-08       Impact factor: 8.110

4.  The Mast Cell-SCF-CB1 Interaction Is a Key Player in Seborrheic Keratosis.

Authors:  Mika Yamanaka-Takaichi; Koji Sugawara; Rieko Sumitomo; Daisuke Tsuruta
Journal:  J Histochem Cytochem       Date:  2020-06-24       Impact factor: 2.479

Review 5.  Regulation of mast cell responses in health and disease.

Authors:  Alasdair M Gilfillan; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2011       Impact factor: 2.214

6.  Mast cells in canine cutaneous hemangioma, hemangiosarcoma and mammary tumors.

Authors:  Moges Woldemeskel; Sreekumari Rajeev
Journal:  Vet Res Commun       Date:  2010-02-03       Impact factor: 2.459

Review 7.  Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation.

Authors:  Steven Maltby; Khashayarsha Khazaie; Kelly M McNagny
Journal:  Biochim Biophys Acta       Date:  2009-02-21

8.  Blood vessel density in Basal cell carcinomas and benign trichogenic tumors as a marker for differential diagnosis in dermatopathology.

Authors:  Julia Winter; Hermann Kneitz; Eva-B Bröcker
Journal:  J Skin Cancer       Date:  2010-10-07

9.  Our perception of the mast cell from Paul Ehrlich to now.

Authors:  Michael A Beaven
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

10.  Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer.

Authors:  Seri N E Sarchio; Richard A Scolyer; Clare Beaugie; David McDonald; Felix Marsh-Wakefield; Gary M Halliday; Scott N Byrne
Journal:  J Invest Dermatol       Date:  2013-10-14       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.